PepVault › Peptides › Semaglutide (oral)
Metabolic & GLP-1 peptide · also known as Rybelsus, Wegovy pill, Ozempic pill, Oral semaglutide
Semaglutide as a daily tablet instead of a weekly shot. It's sold as Rybelsus (3, 7 and 14 mg) and Ozempic tablets (1.5, 4 and 9 mg) for type 2 diabetes, and as Wegovy tablets (up to 25 mg) for weight management. Each line has its own dose steps, so log the strength on your pack.
Semaglutide (oral) is commonly researched at 1.5–25 mg, daily, by Oral tablet. These are reference ranges from the literature and community use, not a prescription.
Estimated half-life: ~1 week. See how it accumulates in the half-life calculator.
Both tablet labels carry the GLP-1 class boxed warning for thyroid C-cell tumors seen in rodents, plus the weekly shot's pancreatitis, gallbladder and low-blood-sugar (with insulin or sulfonylureas) warnings. These are label findings; review them with your clinician.
Open the full Semaglutide (oral) guide (needs JavaScript). PepVault is a private research and tracking tool, not medical advice.
Download PepVault on the App Store (7-day free trial) or try the in-browser demo.